ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Total Liabilities
Everything the company owes to creditors and other parties.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 539.4% from a year ago
Total liabilities stood at $288.65M at the end of Q1 FY2026, up 539.4% from a year earlier and up 15.5% from the prior quarter. Over 3 fiscal years it compounded at +353.6% a year.
Context
- Total liabilities amounted to 49.1% of total assets at the end of Q1 FY2026, down 0.6 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +539.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 249.98M USD
- Year-over-year change
- +478.9%
- 4-year CAGR
- +284.4%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 249.98M | +478.9% |
| FY2024 | 2024-12-31 | 43.18M | +280.2% |
| FY2023 | 2023-12-31 | 11.36M | +323.9% |
| FY2022 | 2022-12-31 | 2.68M | +134.0% |
| FY2021 | 2021-12-31 | 1.14M | — |
Total Liabilities vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +539.4% is the highest of 11, against a peer median of -1.7%.
- Total liabilities amounts to 49.1% of total assets for ASPI, versus a peer median of 53.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$90.97B BRL | -8.3% | +6.3% | 121.4% | |
| Mar 2026 | $4.74B USD | +8.5% | +6.9% | 78.2% | |
| Mar 2026 | $1.14B USD | -4.1% | -4.2% | 48.9% | |
| Mar 2026 | $1.09B USD | -15.8% | -2.5% | 79.9% | |
| Mar 2026 | $877.35M USD | +157.3% | +4.9% | 74.6% | |
| Mar 2026 | $850.63M USD | +11.9% | -15.3% | 55.9% | |
| Mar 2026 | $795.73M USD | -7.4% | -8.8% | 50.1% | |
| Mar 2026 | $443.31M USD | -22.0% | -1.0% | 35.9% | |
| Mar 2026 | $288.65M USD | +539.4% | +353.6% | 49.1% | |
| Apr 2026 | $123.56M USD | +0.7% | +10.1% | 30.2% | |
| Mar 2026 | $16.15M USD | +133.9% | +66.1% | 10.9% | |
| Peer median (excluding ASPI) | — | -1.7% | +2.0% | 53.0% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.95M | 2.39M | 7.91M | 61.89M | 285.56M |
| Short-term Investments | 0 | 0 | 0 | 0 | 47.75M |
| Net Receivables | 0 | 0 | 938.05K | 734.48K | 51.71M |
| Inventory | 0 | 0 | 0 | 65.66K | 8.49M |
| Other Current Assets | 0 | 913.01K | 1.66M | 3.05M | 2.64M |
| Total Current Assets | 3.22M | 3.3M | 10.51M | 65.74M | 398.14M |
| Property, Plant & Equipment (Net) | 3.92M | 9.05M | 11.97M | 23.48M | 34.96M |
| Goodwill | 0 | 0 | 3.27M | 3.17M | 8.57M |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.48M |
| Long-term Investments | 0 | 0 | 0 | 0 | 49M |
| Tax Assets | 0 | 0 | 0 | 5.77M | 14.86M |
| Other Non-current Assets | (1) | 139.64K | 4.44M | (3.81M) | 5.87M |
| Total Non-current Assets | 3.92M | 9.19M | 19.68M | 28.6M | 114.74M |
| Total Assets | 7.14M | 12.5M | 30.19M | 94.35M | 512.88M |
| Account Payables | 59.68K | 1.35M | 1.11M | 1.02M | 5.76M |
| Short-term Debt | 46.9K | 33.85K | 470.4K | 939.11K | 13.64M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 882K | 882K | 882K |
| Other Current Liabilities | 116.2K | 140.46K | 1.97M | 1.26M | 8.84M |
| Total Current Liabilities | 303.35K | 1.94M | 5.67M | 7.06M | 32.7M |
| Long-term Debt | 0 | 0 | 0 | 34.87M | 200.79M |
| Deferred Tax Liabilities | 0 | 0 | 110.58K | 0 | 14.96M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 4.3M | 5.74M | 0 |
| Total Non-current Liabilities | 841.62K | 742.44K | 5.68M | 41.87M | 217.29M |
| Total Liabilities | 1.14M | 2.68M | 11.36M | 43.18M | 249.98M |
| Common Stock | 206.53K | 359.07K | 489.23K | 720.68K | 1.12M |
| Retained Earnings | (2.61M) | (7.55M) | (23.84M) | (56.17M) | (231.27M) |
| Accumulated OCI | 18.72K | 255.03K | (920.98K) | (2.16M) | 2.54M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 2.53M | 3.27M | 58.75M |
| Total Equity | 6M | 9.82M | 18.83M | 51.17M | 262.9M |
| Total Debt | 926.6K | 822.2K | 2.14M | 37.75M | 215.96M |
| Net Debt | (2.03M) | (1.57M) | (5.77M) | (24.14M) | (69.6M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.